Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 2
1991 3
1995 2
1996 1
1997 1
1998 2
1999 1
2001 2
2003 2
2004 4
2005 4
2006 4
2007 5
2008 2
2009 8
2010 9
2011 12
2012 15
2013 20
2014 13
2015 13
2016 12
2017 11
2018 10
2019 11
2020 14
2021 10
2022 14
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23064212

187 results

Results by year

Filters applied: . Clear all
Page 1
64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-p-benzyl-NH-hu14.18K322A.
Leung K. Leung K. 2012 Dec 16 [updated 2013 Mar 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Dec 16 [updated 2013 Mar 14]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23534082 Free Books & Documents. Review.
Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma.
Butch ER, Mead PE, Amador Diaz V, Tillman H, Stewart E, Mishra JK, Kim J, Bahrami A, Dearling JLJ, Packard AB, Stoddard SV, Vāvere AL, Han Y, Shulkin BL, Snyder SE. Butch ER, et al. Cancer Res. 2019 Jun 15;79(12):3112-3124. doi: 10.1158/0008-5472.CAN-18-3340. Epub 2019 Apr 23. Cancer Res. 2019. PMID: 31015228 Free PMC article.
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma.
Federico SM, McCarville MB, Shulkin BL, Sondel PM, Hank JA, Hutson P, Meagher M, Shafer A, Ng CY, Leung W, Janssen WE, Wu J, Mao S, Brennan RC, Santana VM, Pappo AS, Furman WL. Federico SM, et al. Clin Cancer Res. 2017 Nov 1;23(21):6441-6449. doi: 10.1158/1078-0432.CCR-17-0379. Epub 2017 Sep 22. Clin Cancer Res. 2017. PMID: 28939747 Free PMC article. Clinical Trial.
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.
Navid F, Sondel PM, Barfield R, Shulkin BL, Kaufman RA, Allay JA, Gan J, Hutson P, Seo S, Kim K, Goldberg J, Hank JA, Billups CA, Wu J, Furman WL, McGregor LM, Otto M, Gillies SD, Handgretinger R, Santana VM. Navid F, et al. J Clin Oncol. 2014 May 10;32(14):1445-52. doi: 10.1200/JCO.2013.50.4423. Epub 2014 Apr 7. J Clin Oncol. 2014. PMID: 24711551 Free PMC article. Clinical Trial.
187 results